<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Draft Guidance for Industry on Immunogenicity Assessment for Therapeutic Protein Products; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Draft Guidance for Industry on Immunogenicity Assessment for Therapeutic Protein Products; Availability</h1>
    <p class="timestamp">Published: 2013-02-11 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled "Immunogenicity Assessment for Therapeutic Protein Products." Therapeutic protein products may elicit immune responses, and these responses may lead to serious or life-threatening adverse events for the patient or loss of efficacy of the product. This draft guidance is intended to assist manufacturers to develop a risk-based approach in both the preclinical and clinical phases of the d...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2013-03019</p>
    <p><strong>Publication Date:</strong> 2013-02-11</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2013/02/11/2013-03019/draft-guidance-for-industry-on-immunogenicity-assessment-for-therapeutic-protein-products">https://www.federalregister.gov/documents/2013/02/11/2013-03019/draft-guidance-for-industry-on-immunogenicity-assessment-for-therapeutic-protein-products</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2013-03019</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
